play_arrow

keyboard_arrow_right

Listeners:

Top listeners:

skip_previous skip_next
00:00 00:00
playlist_play chevron_left
volume_up
  • cover play_arrow

HHS Cancels 22 mRNA Vaccine Contracts, Citing Ineffectiveness Against Respiratory Viruses

Background

by Worthy News Washington D.C. Bureau Staff

(Worthy News) – In a sweeping move that marks a major shift in U.S. vaccine policy, the Department of Health and Human Services (HHS) announced Tuesday it has canceled 22 contracts worth nearly $500 million related to mRNA vaccine development. The decision follows a weeks-long internal review by HHS’s Biomedical Advanced Research and Development Authority (BARDA).

HHS Secretary Robert F. Kennedy Jr. explained that the cancellations stem from scientific data showing mRNA vaccines are not sufficiently effective against upper respiratory infections like COVID-19 and the flu. The review also raised concerns about the vaccines’ inability to cope with viral mutations.

“We reviewed the science, listened to the experts, and acted,” said Kennedy in a video statement. “BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.”

Among the terminated awards is over $750 million in funding previously allocated to Moderna for developing mRNA-based bird flu vaccines. Other affected entities include Emory University, Tiba Biotech, Luminary Labs, ModeX, and Seqirus. Several pre-award proposals from major pharmaceutical firms, including Pfizer and Sanofi Pasteur, were also rejected under the move.

Kennedy cited the emergence of variants like Omicron–which infected millions, including the vaccinated–as evidence of mRNA’s shortcomings. “A single mutation can make mRNA vaccines ineffective,” he said, warning that these technologies may even fuel viral evolution through a phenomenon known as “antigenic shift.”

While final-stage mRNA contracts with companies like Arcturus and Amplitude will be allowed to run their course to protect prior taxpayer investments, no new BARDA mRNA projects will be initiated. HHS also instructed its investment partner, Global Health Investment Corporation (GHIC), to halt all mRNA-related equity investments.

Despite the decision, mRNA research at the National Institutes of Health (NIH) will continue unaffected.

The HHS Secretary emphasized that the department still supports vaccines, but is now pivoting toward alternatives with stronger safety records and efficacy, such as whole-virus vaccines and next-generation platforms that remain stable even as viruses mutate.

“Let me be absolutely clear,” Kennedy stated, “HHS supports safe, effective vaccines for every American who wants them. That’s why we’re moving beyond the limitations of mRNA and investing in better solutions.”

The announcement signals a broader reorientation of federal vaccine policy, moving away from emergency-era technologies that failed to meet long-term scientific standards in favor of more robust, transparent, and ethically grounded vaccine development.

Copyright 1999-2026 Worthy News. This article was originally published on Worthy News and was reproduced with permission.


Latest News from Worthy News

Egyptian Christian Convert Faces Terror Charges as Trial Opens in Cairo
Egyptian Christian Convert Faces Terror Charges as Trial Opens in Cairo
Tuesday, April 28, 2026

The trial of Egyptian Christian convert Said Mansour Rezk Abdelrazek opened last week in Cairo, drawing renewed international concern over religious freedom in Egypt. Abdelrazek, arrested in July 2025, faces multiple terrorism-related charges tied to his conversion from Islam and efforts to change the religious designation on his identity documents.

Massive Appalachian Lithium Discovery Could Power America for Centuries and Break Foreign Dependence
Massive Appalachian Lithium Discovery Could Power America for Centuries and Break Foreign Dependence
Tuesday, April 28, 2026

A major new study from the U.S. Geological Survey has revealed that the Appalachian region may hold a massive and largely untapped supply of lithium—offering a strategic opportunity for the United States to reclaim mineral independence in an increasingly competitive global market.

FBI Raids Dozens of Minnesota Childcare Centers in Expanding Fraud Probe
FBI Raids Dozens of Minnesota Childcare Centers in Expanding Fraud Probe
Tuesday, April 28, 2026

Federal authorities launched a sweeping crackdown Tuesday as the Federal Bureau of Investigation executed search warrants at nearly two dozen childcare centers across Minneapolis, targeting what officials describe as a growing web of fraud schemes in the Twin Cities.

DeSantis Unveils New Florida Map Amid Escalating National Redistricting Battle
DeSantis Unveils New Florida Map Amid Escalating National Redistricting Battle
Tuesday, April 28, 2026

Florida Governor Ron DeSantis on Monday unveiled a newly configured congressional map that could significantly reshape the balance of power in the U.S. House, countering recent Democratic gains in Virginia and intensifying a growing nationwide redistricting fight.

House GOP Pushes New DHS Funding Bill as Border Security Fight Intensifies
House GOP Pushes New DHS Funding Bill as Border Security Fight Intensifies
Tuesday, April 28, 2026

House Speaker Mike Johnson announced that House Republicans are preparing a new bill to fund the Department of Homeland Security (DHS), as a prolonged funding standoff with Democrats continues to impact key immigration enforcement agencies.

IDF Destroys Massive Hezbollah Tunnel in Southern Lebanon Amid Ceasefire Tensions
IDF Destroys Massive Hezbollah Tunnel in Southern Lebanon Amid Ceasefire Tensions
Tuesday, April 28, 2026

The Israel Defense Forces (IDF) destroyed what it described as the largest Hezbollah tunnel discovered in southern Lebanon on Tuesday evening, carrying out a controlled detonation shortly after issuing an unusual public warning to northern Israeli communities.

Trump Welcomes King Charles to White House, Highlights U.S.-U.K. Alliance
Trump Welcomes King Charles to White House, Highlights U.S.-U.K. Alliance
Tuesday, April 28, 2026

President Donald Trump on Tuesday welcomed King Charles III and Queen Camilla to the White House, emphasizing the enduring alliance between the United States and the United Kingdom as the monarch continued a four-day state visit.

WHO WE ARE

The Psalms, hymns, and spiritual songs encapsulate the beauty, wisdom, and eternal truths found in the Bible, creating an immersive experience that resonates with believers and seekers alike.

CONTACT